[go: up one dir, main page]

AR044055A1 - Monohidrocloruro de risperidona - Google Patents

Monohidrocloruro de risperidona

Info

Publication number
AR044055A1
AR044055A1 ARP040101359A ARP040101359A AR044055A1 AR 044055 A1 AR044055 A1 AR 044055A1 AR P040101359 A ARP040101359 A AR P040101359A AR P040101359 A ARP040101359 A AR P040101359A AR 044055 A1 AR044055 A1 AR 044055A1
Authority
AR
Argentina
Prior art keywords
risperidone
monohidrocloride
monohydrochloride
ion
hemipentahydrate
Prior art date
Application number
ARP040101359A
Other languages
English (en)
Inventor
Reinerus Gerardus Gieling
Jiri Bertl
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of AR044055A1 publication Critical patent/AR044055A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

El monohidrocloruro de risperidona cristalino es un hemipentahidratado. Las sales de monohidrocloruro pueden utilizarse en las composiciones farmacéuticas y métodos de igual forma que los utilizados para tratar trastornos psicóticos. Reivindicación 2: Una sal de hidrocloruro de risperidona, caracterizada porque la relación entre el ión de risperidona y el ión del cloruro está dentro de un rango entre 0,8-1,2:1.
ARP040101359A 2003-04-22 2004-04-22 Monohidrocloruro de risperidona AR044055A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46436403P 2003-04-22 2003-04-22

Publications (1)

Publication Number Publication Date
AR044055A1 true AR044055A1 (es) 2005-08-24

Family

ID=33310877

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP040101359A AR044055A1 (es) 2003-04-22 2004-04-22 Monohidrocloruro de risperidona
ARP040101358A AR044054A1 (es) 2003-04-22 2004-04-22 Sales de risperidona solubles en agua

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP040101358A AR044054A1 (es) 2003-04-22 2004-04-22 Sales de risperidona solubles en agua

Country Status (5)

Country Link
US (2) US20040266791A1 (es)
EP (2) EP1615923A1 (es)
AR (2) AR044055A1 (es)
NO (2) NO20055490L (es)
WO (2) WO2004094414A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
PL1708790T3 (pl) * 2003-12-02 2010-10-29 Pharmaneuroboost N V Zastosowanie pipamperonu oraz antagonisty receptora D2 lub antagonisty receptora serotoniny/dopaminy do leczenia zaburzeń psychotycznych
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1695973A1 (en) * 2005-02-24 2006-08-30 Neuro3D Ocaperidone salt and pharmaceutical compositions containing the same
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
MX337286B (es) 2007-05-25 2016-02-22 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
WO2010105093A2 (en) * 2009-03-12 2010-09-16 Delpor, Inc. Implantable device for long-term delivery of drugs
HUE032310T2 (hu) 2011-04-25 2017-09-28 Shandong luye pharmaceutical co ltd Nyújtott risperidon-leadású mikrogömb kompozíció
WO2012147035A1 (en) 2011-04-26 2012-11-01 Torrent Pharmaceuticals Limited Acid addition salts of risperidone and pharmaceutical compositions thereof
CA2903769A1 (en) 2013-03-11 2014-10-09 Durect Corporation Injectable controlled release composition comprising high viscosity liquid carrier
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
TW202313047A (zh) 2021-09-21 2023-04-01 西班牙商禾霏藥品實驗室有限公司 抗精神病可注射儲積型組合物
AU2023281232A1 (en) 2022-05-18 2024-10-24 Laboratorios Farmacéuticos Rovi, S.A. Prolonged-release injectable compositions for use in treatment with risperidone together with cyp2d6 enzyme inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation

Also Published As

Publication number Publication date
EP1615924A1 (en) 2006-01-18
NO20055490L (no) 2006-01-23
AR044054A1 (es) 2005-08-24
WO2004094415A1 (en) 2004-11-04
NO20055485D0 (no) 2005-11-21
US20040266791A1 (en) 2004-12-30
EP1615923A1 (en) 2006-01-18
US20040266790A1 (en) 2004-12-30
WO2004094414A1 (en) 2004-11-04
NO20055490D0 (no) 2005-11-21
NO20055485L (no) 2006-01-23

Similar Documents

Publication Publication Date Title
AR044055A1 (es) Monohidrocloruro de risperidona
UY27222A1 (es) Pirazolopirimidinas como agentes terapéuticos
UY27300A1 (es) Nuevos derivados de quinolina
NI201800067A (es) Compuestos de diamina-arilsulfonamida sustituidos con hidroxialquilamina e hidroxicicloalquilamina con actividad selectiva en canales de sodio activados por voltaje
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP066365A (es) Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk
DK1648874T3 (da) Piperazinderivater samt deres anvendelse som terapeutisk aktive stoffer
CR9587A (es) Derivados de piridazina
SV2002000197A (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas ref. pc10602/20073/bb
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
AR090349A1 (es) Terapia de combinacion para trastornos proliferativos, kit y uso
CL2012002318A1 (es) Compuestos derivados de tieno [2,3-d]pirimidina, inhibidores de quinasa mnk1 y mnk2; composición farmaceutica; que los comprende; y su uso en el tratamiento de enfermedades metabolicas, hematopoyeticas, neurodegenerativas, renales, inflamatorias y cancer.
AR063188A1 (es) Compuestos intermediarios para la preparacion de trans -5-cloro-2-netil-2,3,3a,12b- tetrahidro-1h-dibenz (2,3:6,7)- oxepina (4,5c) pirrol
AR065797A1 (es) Usos y derivados de 1-(2- (2,4- dimetilfenilsulfanil) fenil) piperazina
AR058163A1 (es) Medicamentos exhaltadores del deseo sexual que comprenden derivados de benzimidazolona
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
AR065798A1 (es) Usos terapeuticos de la 4-[2-(4-metilfenilsulfanil)fenil]piperidina
ES2496669T3 (es) Agentes antitumorales con una estructura de benzofenantridina y formulaciones que los contienen
PA8566301A1 (es) Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades
ES2253378T3 (es) Extractos de espermatofitos con actividad antineoplasica.
UY30029A1 (es) Derivados de piperidina, sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones
UY29741A1 (es) Sales de 1,5- diaril pirazol-3-carboxamidas, procesos de preparación, composeciones farmacéuticas que las contienen, aplicaciones y métodos de uso.
UY27930A1 (es) Derivados de tiazol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal